54gene Archives - AfricaBusiness.com

17Sep

By Africa BusinessNo Comments

Business, Medicine, Tech

54gene Closes $25M Series B to Advance Global Drug Discovery Capabilities

Cathay Africinvest Innovation leads round as company expands precision medicine capabilities across the African continent 54gene, the health technology company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round, led by Cathay AfricInvest Innovation Fund. The round also included participation from Adjuvant Capital, KdT Ventures, Plexo Capital, Endeavor Capital, Ingressive Capital and others. This round brings the company’s total investment to date to more than $45M since being founded in 2019. The new capital raised will be deployed to expand 54gene’s capabilities in sequencing, target identification and validation, and precision medicine clinical trials enabling drug discovery in Africa for both Africans and the global population...

54gene unveils world-class scientific research laboratory in Lagos State, Nigeria

54gene has unveiled its new lab in Lagos State, Nigeria, capable of human whole genome sequencing and a variety of other scientific investigations. Hosting a suite of world-class molecular genomics capabilities, including the Illumina Novaseq 6000 and NextSeq 550Dx the lab is part of 54gene’s mission to enable Africans to conduct genomics research and will be fully operational from January 2021. The new lab, recently inspected by the Commissioner of Health for Lagos State, Prof. Akin Abayomi, is geared to crucially expedite internal and external research projects designed to facilitate precision medicine for Africans and the global population. 54gene is currently conducting research to discover novel biological insights based on genetic modifiers, by deriving information from its unique a...

Illumina collaborates with 54gene in the creation of a world-class genomics facility in Nigeria

Partnership will expand 54gene’s sequencing-based research and molecular diagnostics capabilities with a focus on improving health outcomes through precision medicine 03 September, 2020, Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. The partnership will support the establishment of a new genetics facility in Lagos, Nigeria, equipped with a suite of Illumina's cutting-edge sequencing and high-density microarray technology platforms, which will generate genetic information for health research and drug development. Africa contains more genetic diversity than any other continent because the Afri...